Two induced pluripotent stem cell therapies receive conditional approval in Japan after small clinical trials showed symptom improvement in Parkinson’s and heart failure.
Morning Overview on MSN
Japan approves first treatment made from reprogrammed human cells
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...
When you were first conceived, you were a single cell. From this basic fact, we can extrapolate a few things, most especially that all the cells that make up your body today came (indirectly) from ...
A third "just in case" service to proactively store induced pluripotent stem (iPS) cells created with a client's blood for potential use if they develop future medical issues is s ...
Aspen Neuroscience, Inc., a clinical‑stage biotechnology company pioneering autologous regenerative therapies, today announced that the World Health Organization (WHO) has published Sasineprocel as ...
Stem cells can self-renew and differentiate into a wide variety of cell types, making them critical components in embryonic development. In adults, stem cell populations, such as those in the ...
Tissue-specific “adult” stem cells that are capable of both self-renewal and specialized tissue repair reside in certain tissues, such as the epidermis, limbal tissue of the eye, skeletal muscle, and ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results